Literature DB >> 29017878

Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the causative Leishmania parasites and clinico-epidemiological features.

Yoshihisa Hashiguchi1, Eduardo A L Gomez2, Abraham G Cáceres3, Lenin N Velez2, Nancy V Villegas2, Kazue Hashiguchi4, Tatsuyuki Mimori5, Hiroshi Uezato6, Hirotomo Kato7.   

Abstract

This study provides comprehensive information on the past and current status of the Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador, mainly focusing on the causative Leishmania parasites and clinico-epidemiological features. Available information and data including our unpublished works were analyzed thoroughly. Endemic regions of the Andean-CL (uta) in Peru run from the north Piura/Cajamarca to the south Ayacucho at a wide range of the Pacific watersheds of the Andes through several departments, while in Ecuador those exist at limited and spotted areas in the country's mid-southwestern two provinces, Azuay and Chimborazo. The principal species of the genus Leishmania are completely different at subgenus level, L. (Viannia) peruviana in Peru, and L. (Leishmania) mexicana and L. (L.) major-like (infrequent occurrence) in Ecuador. The Peruvian uta is now prevalent in different age and sex groups, being not clearly defined as found in the past. The precise reasons are not known and should be elucidated further, though probable factors, such as emergence of other Leishmania parasites, non-immune peoples' migration into the areas, etc., were discussed briefly in the text. The Andean-CL cases in Ecuador are more rural than before, probably because of a rapid development of the Leishmania-positive communities and towns, and the change of life-styles of the inhabitants, including newly constructed houses and roads in the endemic areas. Such information is helpful for future management of the disease, not only for Leishmania-endemic areas in the Andes but also for other endemic areas.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Andean cutaneous leishmaniasis; Andean-CL (uta); Clinico-epidemiological features; Ecuador; Leishmania; Peru

Mesh:

Year:  2017        PMID: 29017878     DOI: 10.1016/j.actatropica.2017.09.028

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  A Clinicoepidemiological Study of Pediatric Cutaneous Leishmaniasis in Sinjar Province, Iraq.

Authors:  Nawfal R Hussein
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

2.  Risk factors for cutaneous leishmaniasis in a high-altitude forest region of Peru.

Authors:  Justin T Lana; Andrés Mallipudi; Ernesto J Ortiz; Jairo H Arevalo; Alejandro Llanos-Cuentas; William K Pan
Journal:  Trop Med Health       Date:  2021-05-17

3.  A clinical study of cutaneous leishmaniasis in a new focus in the Kurdistan region, Iraq.

Authors:  Nawfal R Hussein; Amer A Balatay; Zana S M Saleem; Shiraz M Hassan; Mahde S Assafi; Ramzy Sh Sheikhan; Farasheen R Amedi; Shivan S Hafzullah; Mahmood S Hafzullah; Abdulkareem M Xedr; Mohamed T Zebary; Hindreen A Aqrawi
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

Review 4.  Prevalence of Genetically Complex Leishmania Strains With Hybrid and Mito-Nuclear Discordance.

Authors:  Hirotomo Kato; Abraham G Cáceres; Eduardo A Gomez; Ahmed Tabbabi; Daiki Mizushima; Daisuke S Yamamoto; Yoshihisa Hashiguchi
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

5.  Evaluation of leishmanicidal effect of Euphorbia petiolata extract by in vivo anti-leishmanial assay using promastigotes of Leishmania major.

Authors:  Reza Kazemi Oskuee; Mahmoud Reza Jaafari; Mahdi Moghaddasi; Mahdi Rivandi; Fahime Afzaljavan; Mohammad Mohajeri; Mohammad Ramezani
Journal:  Avicenna J Phytomed       Date:  2018 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.